Alphatime [ATMCR] vs Revvity [RVTY] Detailed Stock Comparison
Alphatime
NASDAQ
Loading...
Revvity
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Alphatime wins in 14 metrics, Revvity wins in 3 metrics, with 0 ties. Alphatime appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alphatime | Revvity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.21 | 37.76 | Alphatime |
| Price-to-Book Ratio | 0.10 | 1.35 | Alphatime |
| Debt-to-Equity Ratio | 13.11 | 44.66 | Alphatime |
| PEG Ratio | 0.00 | 16.83 | Alphatime |
| EV/EBITDA | 1.10 | 14.99 | Alphatime |
| Profit Margin (TTM) | 52.78% | 10.19% | Alphatime |
| Operating Margin (TTM) | 0.00% | 14.49% | Revvity |
| EBITDA Margin (TTM) | N/A | 14.49% | N/A |
| Return on Equity | 4.13% | 3.61% | Alphatime |
| Return on Assets (TTM) | 6.12% | 2.07% | Alphatime |
| Free Cash Flow (TTM) | N/A | $541.65M | N/A |
| Dividend Yield | N/A | 0.30% | N/A |
| 1-Year Return | 133.33% | -28.30% | Alphatime |
| Price-to-Sales Ratio (TTM) | 0.01 | 3.60 | Alphatime |
| Enterprise Value | $41.51B | $12.59B | Alphatime |
| EV/Revenue Ratio | 0.21 | 4.50 | Alphatime |
| Gross Profit Margin (TTM) | 49.02% | 54.50% | Revvity |
| Revenue per Share (TTM) | $24 | $23 | Alphatime |
| Earnings per Share (Diluted) | $1.33 | $2.30 | Revvity |
| Beta (Stock Volatility) | -0.01 | 0.92 | Alphatime |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alphatime vs Revvity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alphatime | -1.07% | 0.00% | 16.67% | 86.67% | 75.00% | 21.74% |
| Revvity | 2.56% | -0.77% | -10.63% | -10.66% | -20.91% | -21.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alphatime | 133.33% | -88.43% | -90.31% | -89.31% | -89.31% | -89.31% |
| Revvity | -28.30% | -40.88% | -26.60% | 79.84% | 307.21% | 323.70% |
Performance & Financial Health Analysis: Alphatime vs Revvity
| Metric | ATMCR | RVTY |
|---|---|---|
| Market Information | ||
| Market Cap | $2.29B | $10.08B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 10,355 | 1,688,530 |
| 90 Day Avg. Volume | 30,780 | 1,365,820 |
| Last Close | $0.28 | $88.00 |
| 52 Week Range | $0.14 - $0.30 | $85.12 - $129.50 |
| % from 52W High | -7.67% | -32.05% |
| All-Time High | $4.47 (Mar 08, 2021) | $203.16 (Dec 27, 2021) |
| % from All-Time High | -93.74% | -56.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.04% |
| Quarterly Earnings Growth | -0.73% | -0.03% |
| Financial Health | ||
| Profit Margin (TTM) | 0.53% | 0.10% |
| Operating Margin (TTM) | 0.00% | 0.14% |
| Return on Equity (TTM) | 0.04% | 0.04% |
| Debt to Equity (MRQ) | 13.11 | 44.66 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.78 | $64.29 |
| Cash per Share (MRQ) | $0.00 | $8.44 |
| Operating Cash Flow (TTM) | $44,427 | $584.59M |
| Levered Free Cash Flow (TTM) | $11.01B | $531.58M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.30% |
| Last 12-Month Dividend | $0.00 | $0.28 |
Valuation & Enterprise Metrics Analysis: Alphatime vs Revvity
| Metric | ATMCR | RVTY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.21 | 37.76 |
| Forward P/E | N/A | 16.83 |
| PEG Ratio | 0.00 | 16.83 |
| Price to Sales (TTM) | 0.01 | 3.60 |
| Price to Book (MRQ) | 0.10 | 1.35 |
| Market Capitalization | ||
| Market Capitalization | $2.29B | $10.08B |
| Enterprise Value | $41.51B | $12.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.21 | 4.50 |
| Enterprise to EBITDA | 1.10 | 14.99 |
| Risk & Other Metrics | ||
| Beta | -0.01 | 0.92 |
| Book Value per Share (MRQ) | $2.78 | $64.29 |
Financial Statements Comparison: Alphatime vs Revvity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATMCR | RVTY |
|---|---|---|
| Revenue/Sales | N/A | $664.76M |
| Cost of Goods Sold | N/A | $289.22M |
| Gross Profit | N/A | $375.55M |
| Research & Development | N/A | $53.60M |
| Operating Income (EBIT) | N/A | $72.23M |
| EBITDA | N/A | $172.95M |
| Pre-Tax Income | N/A | $52.38M |
| Income Tax | N/A | $10.71M |
| Net Income (Profit) | N/A | $42.24M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATMCR | RVTY |
|---|---|---|
| Cash & Equivalents | N/A | $1.14B |
| Total Current Assets | N/A | $2.32B |
| Total Current Liabilities | N/A | $648.19M |
| Long-Term Debt | N/A | $3.33B |
| Total Shareholders Equity | N/A | $7.64B |
| Retained Earnings | N/A | $5.88B |
| Property, Plant & Equipment | N/A | $660.38M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATMCR | RVTY |
|---|---|---|
| Operating Cash Flow | N/A | $172.05M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $112.17M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-153.59M |
Short Interest & Institutional Ownership Analysis
| Metric | ATMCR | RVTY |
|---|---|---|
| Shares Short | N/A | 6.05M |
| Short Ratio | N/A | 5.76 |
| Short % of Float | N/A | 0.07% |
| Average Daily Volume (10 Day) | 10,355 | 1,688,530 |
| Average Daily Volume (90 Day) | 30,780 | 1,365,820 |
| Shares Outstanding | 8.28B | 120.65M |
| Float Shares | N/A | 116.90M |
| % Held by Insiders | N/A | 0.00% |
| % Held by Institutions | N/A | 0.98% |
Dividend Analysis & Yield Comparison: Alphatime vs Revvity
| Metric | ATMCR | RVTY |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.28 |
| Last 12-Month Dividend Yield | N/A | 0.30% |
| 3-Year Avg Annual Dividend | $0.04 | $0.28 |
| 3-Year Avg Dividend Yield | 2.74% | 0.06% |
| 3-Year Total Dividends | $0.12 | $0.84 |
| Ex-Dividend Date | Nov 10, 2022 | Apr 17, 2025 |